Ofatumumab, the first human anti-CD20 monoclonal antibody for the treatment of B cell hematologic malignancies

  • Anti-CD20 mAb ofatumumab in CLL and B-NHL
  • Ira V. Gupta, Roxanne C. Jewell
  • Annals of the New York Academy of Sciences, July 2012, Wiley
  • DOI: 10.1111/j.1749-6632.2012.06661.x

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1111/j.1749-6632.2012.06661.x

In partnership with:

Link to Wiley showcase